Targeting TNF and Its Family Members in Autoimmune/Inflammatory Disease

Targeting TNF and Its Family Members in Autoimmune/Inflammatory Disease

Saved in:

Bibliographic Details
Main Authors:	Sophie Desplat-Jégo, Linda Burkly, Chaim Putterman
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2014/628748
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TNF and TNF Receptor Superfamily Members in HIV infection: New Cellular Targets for Therapy?
by: Amit Kumar, et al.
Published: (2013-01-01)

Control of Cytotoxic Lymphocyte Survival in Vivo By Members of the TNF-R Family
by: Eckhard R. Podack
Published: (2001-01-01)

The Role of TNF-α and TNF Superfamily Members in the Pathogenesis of Calcific Aortic Valvular Disease
by: Antonella Galeone, et al.
Published: (2013-01-01)

Autoimmune Hepatitis Triggered by Anti-TNF- Therapy
by: Satoshi Nakayama
Published: (2013-01-01)

TNF-Like Weak Inducer of Apoptosis Aggravates Left Ventricular Dysfunction after Myocardial Infarction in Mice
by: Kai-Uwe Jarr, et al.
Published: (2014-01-01)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
by: Julie Schwartzman-Morris, et al.
Published: (2012-01-01)

IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
by: Xiaoyu Cui, et al.
Published: (2025-06-01)

Single-cell RNA sequencing for the study of lupus nephritis
by: Jill Buyon, et al.
Published: (2019-12-01)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
by: Romain Altwegg, et al.
Published: (2014-01-01)

Th17 Response and Inflammatory Autoimmune Diseases
by: Janelle C. Waite, et al.
Published: (2012-01-01)

Editorial: Anti-inflammatory diet in autoimmune diseases
by: Ifigenia Kostoglou-Athanassiou, et al.
Published: (2024-10-01)

Therapeutic administration of the chemokine CXCL1/KC abrogates autoimmune inflammatory heart disease.
by: Kurt Bachmaier, et al.
Published: (2014-01-01)

Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
by: PLOS ONE Staff
Published: (2017-01-01)

Animal models of neuropsychiatric systemic lupus erythematosus: deciphering the complexity and guiding therapeutic development
by: Baruh Polis, et al.
Published: (2024-12-01)

Autoimmunity in inflammatory bowel disease: a case of ulcerative colitis with diabetes mellitus, autoimmune hepatitis and autoimmune hypothyroidism
by: Mehri Najafi, et al.
Published: (2012-12-01)

Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune disorders: a comprehensive review
by: Zhiyong Long, et al.
Published: (2024-10-01)

Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?
by: Zhonghui Wen, et al.
Published: (2004-01-01)

Identification of Orch3, a locus controlling dominant resistance to autoimmune orchitis, as kinesin family member 1C.
by: Roxana del Rio, et al.
Published: (2012-01-01)

Commentary: Anti-TNFα in inflammatory bowel disease: from originators to biosimilars
by: Yingjie Liu, et al.
Published: (2025-07-01)

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets
by: Xiaoshuang Song, et al.
Published: (2025-07-01)

Constitutive reduction in the checkpoint inhibitor, CTLA-4, does not accelerate SLE in NZM 2328 mice
by: William Stohl, et al.
Published: (2019-12-01)

Prospective screening of family members with moyamoya disease patients.
by: Cong Han, et al.
Published: (2014-01-01)

The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
by: Taku Kuwabara, et al.
Published: (2017-01-01)

The manifestations of autoimmune processes in the ovaries in women with pelvic inflammatory diseases
by: M. L. Dmitriyeva, et al.
Published: (2012-08-01)

Editorial: Natural products and their derivatives in the treatment of inflammatory and autoimmune diseases
by: Mohamed El-Shazly, et al.
Published: (2025-05-01)

Familial Aggregation and Segregation Analysis in Families Presenting Autoimmunity, Polyautoimmunity, and Multiple Autoimmune Syndrome
by: John Castiblanco, et al.
Published: (2015-01-01)

Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still’s Disease
by: Po-Ku Chen, et al.
Published: (2020-01-01)

New insight in treating autoimmune diseases by targeting autophagy
by: Jiao Lyu, et al.
Published: (2024-12-01)

How (Ultra‐)Rare Gene Variants Improve Our Understanding of More Common Autoimmune and Inflammatory Diseases
by: Alexandre Belot, et al.
Published: (2025-02-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
by: Yaqi Zhou, et al.
Published: (2023-07-01)

The Role of TL1A and DR3 in Autoimmune and Inflammatory Diseases
by: Yoshihiro Aiba, et al.
Published: (2013-01-01)

Editorial: The safety and efficacy of ustekinumab in anti-TNFα refractory pediatric inflammatory bowel disease
by: Katelynn K. Ho, et al.
Published: (2025-03-01)

Involvement of HLADQA1*05 in Patients with Inflammatory Bowel Disease Treated with Anti-TNF Drugs
by: Anna Pau, et al.
Published: (2025-01-01)

Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF
by: Roosmarijn E. Vandenbroucke, et al.
Published: (2013-05-01)

Autoimmune/Inflammatory Syndrome Induced by Adjuvants
by: A. A. Zayaeva, et al.
Published: (2024-01-01)

TNFα levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine.
by: Alessia Franceschini, et al.
Published: (2013-01-01)

Bilingualism in the Jordanian-Russian Family Residing in Jordan and its Impact on Communication Between its Members
by: Hazaymeh Omar Mohammad-Ameen Ahmad
Published: (2025-06-01)

Disease and treatment burden in patients with leukaemia: family members/partner perspective
by: Esther Natalie Oliva, et al.
Published: (2025-05-01)

Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE study
by: Ignacio Marin-Jimenez, et al.
Published: (2020-12-01)

Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease
by: Stavroula A. Paschou, et al.
Published: (2018-01-01)